RVPH vs. META

Last updated Jul 21, 2026

RVPH (Reviva Pharmaceuticals Holdings, Inc.) and META (Meta Platforms, Inc.) are both stocks. RVPH operates in Biotechnology (Healthcare), while META operates in Internet Content & Information (Communication Services). Over the past 5 years, RVPH returned -62.72%/yr vs 13.48%/yr for META. At a 0.08 correlation, their price movements are largely independent.

Performance

RVPH vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Reviva Pharmaceuticals Holdings, Inc. (RVPH) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RVPH achieves a -90.32% return, which is significantly lower than META's -1.98% return.

RVPH

• 1D: -4.42%
• 1M: -11.48%
• 6M: -92.50%
• YTD: -90.32%
• 1Y: -93.23%
• 3Y*: -82.42%
• 5Y*: -62.72%
• 10Y*: —
• ALL TIME*: -53.15%

META

• 1D: -0.02%
• 1M: 11.89%
• 6M: 4.31%
• YTD: -1.98%
• 1Y: -8.00%
• 3Y*: 30.34%
• 5Y*: 13.48%
• 10Y*: 18.34%
• ALL TIME*: 21.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RVPH vs. META - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
RVPH Reviva Pharmaceuticals Holdings, Inc.	-90.32%	-84.59%	-64.85%	21.18%	47.06%	-66.95%	-16.40%	6.19%	2.07%
META Meta Platforms, Inc.	-1.98%	13.09%	66.05%	194.13%	-64.22%	23.13%	33.09%	56.57%	-17.77%

Correlation

The correlation between RVPH and META is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (All Time) Calculated using the full available price history since Oct 18, 2018	0.08

Fundamentals

Market Cap RVPH : $7.08M META : $1.64T
EPS RVPH : -$4.17M META : $27.47
PB Ratio RVPH : 0.22 META : 6.80
Total Revenue (TTM) RVPH : $0.00 META : $214.96B
Gross Profit (TTM) RVPH : $0.00 META : $176.14B
EBITDA (TTM) RVPH : -$20.20T META : $106.31B

Return for Risk

RVPH vs. META — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVPH

RVPH Risk / Return Rank: 12
RVPH Sharpe Ratio Rank: 20
RVPH Sortino Ratio Rank: 15
RVPH Omega Ratio Rank: 14
RVPH Calmar Ratio Rank: 5
RVPH Martin Ratio Rank: 9

META

META Risk / Return Rank: 35
META Sharpe Ratio Rank: 36
META Sortino Ratio Rank: 33
META Omega Ratio Rank: 33
META Calmar Ratio Rank: 37
META Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVPH vs. META - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Reviva Pharmaceuticals Holdings, Inc. (RVPH) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RVPH	META	Difference
Sharpe ratio: Return per unit of total volatility	-0.56	-0.21	-0.36
Sortino ratio: Return per unit of downside risk	-0.88	-0.03	-0.85
Omega ratio: Gain probability vs. loss probability	0.88	1.00	-0.12
Calmar ratio: Return relative to maximum drawdown	-0.95	-0.24	-0.71
Martin ratio: Return relative to average drawdown	-1.39	-0.45	-0.94

RVPH vs. META - Sharpe Ratio Comparison

The current RVPH Sharpe Ratio is -0.56, which is lower than the META Sharpe Ratio of -0.21. The chart below compares the historical Sharpe Ratios of RVPH and META, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RVPH vs. META - Drawdown Comparison

The maximum RVPH drawdown since its inception was -99.86%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for RVPH and META.

Drawdown Indicators

	RVPH	META	Difference
Max Drawdown Largest peak-to-trough decline	-99.86%	-76.74%	-23.12%
Max Drawdown (1Y) Largest decline over 1 year	-98.02%	-33.30%	-64.72%
Max Drawdown (3Y) Largest decline over 3 years	-99.72%	-34.15%	-65.57%
Max Drawdown (5Y) Largest decline over 5 years	-99.81%	-76.74%	-23.07%
Max Drawdown (10Y) Largest decline over 10 years	—	-76.74%	—
Current Drawdown Current decline from peak	-99.77%	-17.98%	-81.79%
Average Drawdown Average peak-to-trough decline	-56.16%	-15.88%	-40.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	66.85%	17.63%	+49.22%

Volatility

RVPH vs. META - Volatility Comparison

Reviva Pharmaceuticals Holdings, Inc. (RVPH) has a higher volatility of 33.63% compared to Meta Platforms, Inc. (META) at 14.95%. This indicates that RVPH's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RVPH	META	Difference
Volatility (1M) Calculated over the trailing 1-month period	33.63%	14.95%	+18.68%
Volatility (6M) Calculated over the trailing 6-month period	145.41%	31.08%	+114.33%
Volatility (1Y) Calculated over the trailing 1-year period	166.11%	38.77%	+127.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	130.56%	44.59%	+85.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	114.17%	39.00%	+75.17%

Dividends

RVPH vs. META - Dividend Comparison

RVPH has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.33%.

Position	TTM	2025	2024
META Meta Platforms, Inc.	0.33%	0.32%	0.34%
RVPH Reviva Pharmaceuticals Holdings, Inc.	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both RVPH and META in my portfolio?

RVPH and META have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RVPH or META?

RVPH has higher volatility (33.63%) compared to META (14.95%). In terms of maximum drawdown, RVPH dropped -99.86% vs META's -76.74%.

Which has better risk-adjusted returns?

META currently has the higher Sharpe Ratio (-0.21 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.